Back
Labcorp Holdings Inc. (LH)
Health CareLH · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$314.20
+0.71%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$10.46
ROE
11.0%
Gross margin
28.8%
Debt/Equity
0.83x
Revenue growth
5.8%
Labcorp Holdings Inc. — company intelligence
Earnings surprises
Q2 2026$4.99 vs $4.92 est+1.4%
Q1 2026$4.25 vs $4.21 est+1.0%
Q4 2025$4.07 vs $4.06 est+0.3%
Q3 2025$4.18 vs $4.26 est-1.8%
Analyst consensus · 27 analysts
21 Buy6 Hold0 Sell
Updated Oct 7, 2026
Insider activity · 90 days
4 buys4 sellsnet -2,525 shares
Vaughn Bryan TBuy 1,500 · Sep 1, 2026
Caveney Brian JBuy 3,000 · Sep 1, 2026
Meltzer Jonathan CBuy 900 · Sep 1, 2026
Recent SEC filings
8-K — Material event reportSep 30, 2026
8-K — Material event reportSep 22, 2026
8-K — Material event reportSep 10, 2026
Latest news
Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy — SeekingAlpha · 2w ago
Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day — Yahoo · 2w ago
Is Labcorp Holdings Stock Outperforming the Dow? — Yahoo · 2w ago
Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts — SeekingAlpha · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.